Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas

被引:49
作者
Aulmann, S. [1 ]
Longerich, T. [1 ]
Schirmacher, P. [1 ]
Mechtersheimer, G. [1 ]
Penzel, R. [1 ]
机构
[1] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany
关键词
alveolar soft part sarcoma; fluorescence in situ hybridization; RT-PCR;
D O I
10.1111/j.1365-2559.2007.02693.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Alveolar soft part sarcoma (ASPS) is a rare soft tissue tumour with unique morphology and a recurrent, non-reciprocal translocation der(17)t(X;17)(p11.2;q25) leading to the fusion of ASPSCR1 (also known as ASPL) to the transcription factor TFE3. Although diagnosis is straightforward in classical cases, tumours with atypical morphological features may be difficult to classify solely on the basis of conventional histopathology. The aim of this study was to analyse the chromosomal breakpoints in paraffin-embedded tissue. Methods and results: Three male and two female ASPS patients including one case with uncommon histology were investigated by fluorescence in situ hybridization with split- and fusion-probes. The presence of the resulting ASPSCR1-TFE3 fusion transcripts was assessed by reverse transcriptase-polymerase chain reaction. Hybridization results showed a t(X;17)(p11.2;q25) in all tumours with a duplication of the telomeric part of chromosome Xp. In addition to wild-type TFE3, ASPSCR1-TFE3 fusion transcripts (three type 1 and two type 2 transcripts) were detected in all cases. Conclusions: Molecular confirmation of ASPSCR1-TFE3 gene fusion is applicable to routinely processed archival and diagnostic tumour samples and aids in the differential diagnosis of ASPS.
引用
收藏
页码:881 / 886
页数:6
相关论文
共 22 条
[1]   Alveolar soft part sarcoma - A rare and enigniatic entity [J].
Anderson, ME ;
Hornicek, FJ ;
Gebhardt, MC ;
Raskin, KA ;
Mankin, HJ .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (438) :144-148
[2]   A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23) [J].
Argani, P ;
Lui, MY ;
Couturier, J ;
Bouvier, R ;
Fournet, JC ;
Ladanyi, M .
ONCOGENE, 2003, 22 (34) :5374-5378
[3]   Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay [J].
Argani, P ;
Lal, P ;
Hutchinson, B ;
Lui, MY ;
Reuter, VE ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :750-761
[4]  
AUERBACH HE, 1987, CANCER-AM CANCER SOC, V60, P66, DOI 10.1002/1097-0142(19870701)60:1<66::AID-CNCR2820600112>3.0.CO
[5]  
2-9
[6]  
CHRISTOPHERSON WM, 1952, CANCER, V5, P100, DOI 10.1002/1097-0142(195201)5:1<100::AID-CNCR2820050112>3.0.CO
[7]  
2-K
[8]   Fusion of splicing factor genes PSF and NonO (p54(nrb)) to the TFE3 gene in papillary renal cell carcinoma [J].
Clark, J ;
Lu, YJ ;
Sidhar, SK ;
Parker, C ;
Gill, S ;
Smedley, D ;
Hamoudi, R ;
Linehan, WM ;
Shipley, J ;
Cooper, CS .
ONCOGENE, 1997, 15 (18) :2233-2239
[9]  
Gómez JA, 1999, ARCH PATHOL LAB MED, V123, P503
[10]   Nonrandom cell-cycle timing of a somatic chromosomal translocation: the t(X;17) of alveolar soft-part sarcoma occurs in G2 [J].
Huang, HY ;
Lui, MY ;
Ladanyi, M .
GENES CHROMOSOMES & CANCER, 2005, 44 (02) :170-176